CYP4A11 is repressed by retinoic acid in human liver cells

FEBS Letters

Volumn 580, Issue 14, 2006, Pages 3361-3367

  Antoun, Joseph ^a   Amet, Yolande ^a   Simon, Brigitte ^a   Dréano, Yvonne ^a   Corlu, Anne ^b   Corcos, Laurent ^a,c   Salaun, Jean Pierre ^a,d   Plée Gautier, Emmanuelle ^a,d  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c CHU MORVAN   (France)

^d CNRS   (France)

Author keywords

Cytochrome P450; Fatty acid hydroxylase; HepaRG; Human hepatoma cells; Liver; Retinoic acid

Indexed keywords

APOPROTEIN; CYTOCHROME P450 4A11; LAURIC ACID; RETINOIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; GENE CONTROL; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; LIVER NEOPLASMS; PPAR ALPHA; RNA, MESSENGER; TRETINOIN;

EID: 33744532041     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.006     Document Type: Article

References (46)

1. Hoch U., Zhang Z., Kroetz D.L., and Ortiz de Montellano P.R. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch. Biochem. Biophys. 373 (2000) 63-71
2. Powell P.K., Wolf I., and Lasker J.M. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Arch. Biochem. Biophys. 335 (1996) 219-226
3. Imaoka S., Ogawa H., Kimura S., and Gonzalez F.J. Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. DNA Cell. Biol. 12 (1993) 893-899
4. Bellamine A., Wang Y., Waterman M.R., Gainer III J.V., Dawson E.P., Brown N.J., and Capdevila J.H. Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch. Biochem. Biophys. 409 (2003) 221-227
5. Holla V.R., Adas F., Imig J.D., Zhao X., Price Jr. E., Olsen N., Kovacs W.J., Magnuson M.A., Keeney D.S., Breyer M.D., Falck J.R., Waterman M.R., and Capdevila J.H. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. USA 98 (2001) 5211-5216
6. Kroetz D.L., Yook P., Costet P., Bianchi P., and Pineau T. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 273 (1998) 31581-31589
7. Imaoka S., Yamaguchi Y., and Funae Y. Induction and regulation of cytochrome P450 K-5 (lauric acid hydroxylase) in rat renal microsomes by starvation. Biochim. Biophys. Acta 1036 (1990) 18-23
8. Johnson E.F., Palmer C.N., Griffin K.J., and Hsu M.H. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10 (1996) 1241-1248
9. Savas U., Hsu M.H., and Johnson E.F. Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch. Biochem. Biophys. 409 (2003) 212-220
10. Raucy J.L., Lasker J., Ozaki K., and Zoleta V. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol. Sci. 79 (2004) 233-241
11. Standeven A.M., Thacher S.M., Yuan Y.D., Escobar M., Vuligonda V., Beard R.L., and Chandraratna R.A. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents. Biochem. Pharmacol. 62 (2001) 1501-1509
12. Wuttge D.M., Romert A., Eriksson U., Torma H., Hansson G.K., and Sirsjo A. Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis. FASEB J. 15 (2001) 1221-1223
13. Hargrove G.M., Junco A., and Wong N.C. Hormonal regulation of apolipoprotein AI. J. Mol. Endocrinol. 22 (1999) 103-111
14. Schweizer M., Roder K., Zhang L., and Wolf S.S. Transcription factors acting on the promoter of the rat fatty acid synthase gene. Biochem. Soc. Trans. 30 (2002) 1070-1072
15. Zhou D., Zaiger G., Ghebremeskel K., Crawford M.A., and Reifen R. Vitamin A deficiency reduces liver and colon docosahexaenoic acid levels in rats fed high linoleic and low alpha-linolenic acid diet. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 383-389
16. Paolini M., Antelli A., Pozzetti L., Spetlova D., Perocco P., Valgimigli L., Pedulli G.F., and Cantelli-Forti G. Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in beta-carotene supplemented rats. Carcinogenesis 22 (2001) 1483-1495
17. de Almeida Vasconcelos Fonseca E.M., Chagas C.E., Mazzantini R.P., Heidor R., Ong T.P., and Moreno F.S. All-trans and 9-cis retinoic acids, retinol and {beta}-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis 26 (2005) 1940-1946
18. Baba M., Iishi H., Yamamoto R., and Tatsuta M. Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene protein in Sprague-Dawley rats. Int. J. Cancer 49 (1991) 467-470
19. Ledda-Columbano G.M., Pibiri M., Molotzu F., Cossu C., Sanna L., Simbula G., Perra A., and Columbano A. Induction of hepatocyte proliferation by retinoic acid. Carcinogenesis 25 (2004) 2061-2066
20. Alisi A., Leoni S., Piacentani A., and Conti Devirgiliis L. Retinoic acid modulates the cell-cycle in fetal rat hepatocytes and HepG2 cells by regulating cyclin-cdk activities. Liver Int. 23 (2003) 179-186
21. Takai K., Okuno M., Yasuda I., Matsushima-Nishiwaki R., Uematsu T., Tsurumi H., Shiratori Y., Muto Y., and Moriwaki H. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology 48 (2005) 39-45
22. Aninat C., Piton A., Glaise D., Le Charpentier T., Langouet S., Morel F., Guguen-Guillouzo C., and Guillouzo A. Expression of Cytochromes P450, Conjugating enzymes and Nuclear receptors in human HepaRG Cells. Drug Metab. Dispos. (2005)
23. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., Guyomard C., Lucas J., Trepo C., and Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99 (2002) 15655-15660
24. Amet Y., Berthou F., Baird S., Dreano Y., Bail J.P., and Menez J.F. Validation of the (omega - 1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochem. Pharmacol. 50 (1995) 1775-1782
25. Amet Y., Berthou F., Goasduff T., Salaun J.P., Le Breton L., and Menez J.F. Evidence that cytochrome P450 2E1 is involved in the (omega - 1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Commun. 203 (1994) 1168-1174
26. Olson J.A. Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J. Natl. Cancer Inst. 73 (1984) 1439-1444
27. Ross A.C. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J. 7 (1993) 317-327
28. Amet Y., Berthou F., and Menez J.F. Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin in human and rat liver microsomes. J. Chromatogr. B Biomed. Appl. 681 (1996) 233-239
29. Berthou F., Dreano Y., Belloc C., Kangas L., Gautier J.C., and Beaune P. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochem. Pharmacol. 47 (1994) 1883-1895
30. Allenby G., Bocquel M.T., Saunders M., Kazmer S., Speck J., Rosenberger M., Lovey A., Kastner P., Grippo J.F., Chambon P., et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 90 (1993) 30-34
31. Shaw N., Elholm M., and Noy N. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. J. Biol. Chem. 278 (2003) 41589-41592
32. Le Quere V., Plee-Gautier E., Potin P., Madec S., and Salaun J.P. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. J. Lipid Res. 45 (2004) 1446-1458
33. Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J. Am. Acad. Dermatol. 45 (2001) S158-S167
34. Pfahl M. Signal transduction by retinoid receptors. Skin Pharmacol. 6 Suppl 1 (1993) 8-16
35. Tsuzuki S., Kitajima K., Nakano T., Glasow A., Zelent A., and Enver T. Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol. Cell. Biol. 24 (2004) 6824-6836
36. Giuliano C.J., Kerley-Hamilton J.S., Bee T., Freemantle S.J., Manickaratnam R., Dmitrovsky E., and Spinella M.J. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim. Biophys. Acta 1731 (2005) 48-56
37. Subbaramaiah K., Cole P.A., and Dannenberg A.J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res. 62 (2002) 2522-2530
38. Lee M.O., Kang H.J., Kim Y.M., Oum J.H., and Park J. Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Eur. J. Biochem. 269 (2002) 1162-1170
39. Ramirez C.J., Haberbusch J.M., Soprano D.R., and Soprano K.J. Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells. J. Cell Biochem. 96 (2005) 170-182
40. Elizondo G., Corchero J., Sterneck E., and Gonzalez F.J. Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta. J. Biol. Chem. 275 (2000) 39747-39753
41. Magee T.R., Cai Y., El-Houseini M.E., Locker J., and Wan Y.J. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors. J. Biol. Chem. 273 (1998) 30024-30032
42. Lopez-Carballo G., Moreno L., Masia S., Perez P., and Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 277 (2002) 25297-25304
43. Yeh C.S., Wang J.Y., Cheng T.L., Juan C.H., Wu C.H., and Lin S.R. Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett. (2005)
44. Bollag W., and Ott F. Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas. Agents Actions 1 (1970) 172-175
45. Smith M.A., Parkinson D.R., Cheson B.D., and Friedman M.A. Retinoids in cancer therapy. J. Clin. Oncol. 10 (1992) 839-864
46. Lacroix A., Doskas C., and Bhat P.V. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy. Cancer Res. 50 (1990) 5731-5734